UI 095/UI 096/UI 097/UI 098
Alternative Names: UI-095/UI-096/UI-097/UI-098Latest Information Update: 23 Mar 2024
At a glance
- Originator Korea United Pharm Inc
- Class Antihypertensives
- Mechanism of Action Lipid modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Hypertension; Lipid metabolism disorders
Most Recent Events
- 04 Mar 2024 Early research in Lipid metabolism disorders in South Korea (unspecified route) before March 2024 (Korea United Pharm pipeline, March 2024)
- 04 Mar 2024 Early research in Unspecified in South Korea (unspecified route) before March 2024 (Korea United Pharm pipeline, March 2024)